Acknowledgement
This research was supported by the National Research Foundation of Korea (NRF) grants funded by the Ministry of Education (NRF-2019R1F1A1060368, NRF-2021R1I1A3049699).
References
- Chinn S, Caldwell W, Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr Pain Headache Rep 2016; 20: 25.
- On AY, Tanigor G, Baydar DA. Relationships of autonomic dysfunction with disease severity and neuropathic pain features in fibromyalgia: is it really a sympathetically maintained neuropathic pain? Korean J Pain 2022; 35: 327-35. https://doi.org/10.3344/kjp.2022.35.3.327
- Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160-72. https://doi.org/10.1002/art.1780330203
- Ghavidel-Parsa B, Bidari A, Hajiabbasi A, Shenavar I, Ghalehbaghi B, Sanaei O. Fibromyalgia diagnostic model derived from combination of American College of Rheumatology 1990 and 2011 criteria. Korean J Pain 2019; 32: 120-8. https://doi.org/10.3344/kjp.2019.32.2.120
- Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003; 17: 685-701. https://doi.org/10.1016/S1521-6942(03)00035-4
- Carville SF, Arendt-Nielsen L, Bliddal H, Blotman F, Branco JC, Buskila D, et al.; EULAR. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008; 67: 536-41. Erratum in: Ann Rheum Dis 2015; 74: 476.
- Arnold LM, Clauw DJ, McCarberg BH; FibroCollaborative. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 2011; 86: 457-64. https://doi.org/10.4065/mcp.2010.0738
- Bidari A, Ghavidel Parsa B, Ghalehbaghi B. Challenges in fibromyalgia diagnosis: from meaning of symptoms to fibromyalgia labeling. Korean J Pain 2018; 31: 147-54. https://doi.org/10.3344/kjp.2018.31.3.147
- Lee YS, Kim NH, Sohn HS, Choi KE, Shin HT. Development of drug utilization review guidelines for therapeutic duplication of antipyretics, analgesics, and anti-inflammatory drugs registered in Korea. Korean J Clin Pharm 2010; 20: 213-20. https://doi.org/10.1111/j.1365-2125.2010.03688.x
- Kim SH, Bae GR, Lim HS. Prevalence and risk factors of fibromyalgia syndrome and chronic widespread pain in two communities in Korea-first report in Korean. J Rheum Dis 2006; 13: 18-25.
- Lee HJ, Choi E, Nahm FS, Choi SS, Kim YH, Moon JY, et al. Prevalence of fibromyalgia in fourteen Korean tertiary care university hospital pain clinics. J Pain Res 2018; 11: 2417-23. https://doi.org/10.2147/JPR.S172221
- Forseth KO, Gran JT, Husby G. A population study of the incidence of fibromyalgia among women aged 26-55 yr. Br J Rheumatol 1997; 36: 1318-23. https://doi.org/10.1093/rheumatology/36.12.1318
- Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT, Gren LH, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 2006; 12: 124-8. https://doi.org/10.1097/01.rhu.0000221817.46231.18
- Wolfe F, Walitt B, Perrot S, Rasker JJ, Hauser W. Fibromyalgia diagnosis and biased assessment: sex, prevalence and bias. PLoS One 2018; 13: e0203755.
- Hadker N, Garg S, Chandran AB, Crean SM, McNett M, Silverman SL. Primary care physicians' perceptions of the challenges and barriers in the timely diagnosis, treatment and management of fibromyalgia. Pain Res Manag 2011; 16: 440-4. https://doi.org/10.1155/2011/367059
- Sommer C, Hauser W, Alten R, Petzke F, Spath M, Tolle T, et al. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. Schmerz 2012; 26: 297-310. German. https://doi.org/10.1007/s00482-012-1172-2
- Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choiniere M, et al.; National Fibromyalgia Guideline Advisory Panel. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag 2013; 18: 119-26.
- Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Hauser W, Fluss E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2017; 76: 318-28. https://doi.org/10.1136/annrheumdis-2016-209724
- Sarzi-Puttini P, Torta R, Marinangeli F, Biasi G, Spath M, Buskila D, et al.; Italian Fibromyalgia Network. Fibromyalgia syndrome: the pharmacological treatment options. Reumatismo 2008; 60 Suppl 1: 50-8. https://doi.org/10.4081/reumatismo.2008.1s.50
- Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007; 27: 10000-6. https://doi.org/10.1523/JNEUROSCI.2849-07.2007
- Brummett CM, Janda AM, Schueller CM, Tsodikov A, Morris M, Williams DA, et al. Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty: a prospective, observational cohort study. Anesthesiology 2013; 119: 1434-43. https://doi.org/10.1097/ALN.0b013e3182a8eb1f
- Lee JH. Still a threatening opioid wave: it is time for the protagonist to step up! Korean J Pain 2023; 36: 1-3. https://doi.org/10.3344/kjp.22403
- Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292: 2388-95. https://doi.org/10.1001/jama.292.19.2388
- McNett M, Goldenberg D, Schaefer C, Hufstader M, Baik R, Chandran A, et al. Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States. Curr Med Res Opin 2011; 27: 673-83. https://doi.org/10.1185/03007995.2011.553214